Access
To read this article in full you will need to log-in or choose from the options on the right.
Distillery: Therapeutics - Cancer
SciBX 2(42); doi:10.1038/scibx.2009.1565
Published online Oct. 29 2009
Extra navigation
TTK protein kinase (TTK; MPS1)
A study in cell culture suggests that antagonizing MPS1 could increase the efficacy of paclitaxel in treating cancer. Further details on the research, next steps and licensing status are discussed in the article.
To read this article in full you will need to log-in or choose from the options on the right.
